Veradermics MANE
NYSE MANE
$138.35 +1.69 (+1.24%)
As of: Oct 22, 2026 · 3:30 PM EDT

Veradermics (MANE) Change in Other Operating Assets (2025 - 2026)

Updated

Analysis

Veradermics (MANE) Change in Other Operating Assets (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn -
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn -122.00 Mn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn 188.00 Mn
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn -
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn -
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn -
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 13.00 Mn
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn -
10 Veradermics 5.56 Bn 4.16 Bn - -1.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.34 Mn
Mar 31, 2026 -4.19 Mn
Jun 30, 2025 893,000.00
Mar 31, 2025 -79,000.00
API Access

Veradermics Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=MANE&period=max&api_key=YOUR_API_KEY